Partnership Zeon Corporation Invests in UK’s Chemify to Speed Up Digital Chemistry Innovation

Source: Press release Zeon Corporation 2 min Reading Time

Related Vendors

Zeon Corporation has partnered with Chemify for accelerating the design, discovery, and synthesis of novel molecules for medicines and advanced materials.

Zeon Corporation has strategically invested in and partnered with Chemify, a U.K. growth-stage company and pioneer in digital chemistry.  (Source:  Pixabay)
Zeon Corporation has strategically invested in and partnered with Chemify, a U.K. growth-stage company and pioneer in digital chemistry.
(Source: Pixabay)

Tokyo/Japan – Zeon Corporation, through its venture capital arm Zeon Ventures, has strategically invested in and partnered with Chemify, a U.K. growth-stage company and pioneer in digital chemistry for accelerating the design, discovery, and synthesis of novel molecules for medicines and advanced materials.

Chemify is at the forefront of digitizing and automating the entire chemical discovery and synthesis process. Chemify’s Chemputation technology translates target molecules into proven chemical code that runs directly on the company’s robotic systems, enabling fully automated Design–Make–Test–Analyze cycles. By automating the end-to-end cycle from molecular design to synthesis and analysis, Chemify can access novel chemical space and potentially achieve a 10-fold reduction in the time required from initial conception to compound synthesis. Last year, Chemify opened its first Chemifarm, a fully automated chemistry facility in Glasgow, Scotland, one of the world's most advanced laboratories for molecular design and synthesis. This facility enables automated synthesis and rapid iteration for the discovery of novel small molecules moving from code to compound faster than ever, fueling innovations in advanced materials and beyond.

Stay up to Date

Do you want the latest news, specialist articles and information on new products? Then you can register for our free newsletter:

Choose your Newsletter

The development of novel, makeable molecules is essential to helping address global challenges in human health, energy conservation, and environmental sustainability. Zeon has been an early adopter of digital transformation in chemical research, seeking to redefine the future of R&D since the field's infancy. Through this investment and partnership, we aim to leverage Chemify’s cutting-edge technology to further accelerate our digital chemistry initiatives and drive the creation of new materials and compounds that can provide meaningful solutions to society’s most pressing challenges.

In the Stage30 medium-term management plan, Zeon aims to raise the sales ratio of four growth areas (Mobility, Healthcare and Life Science, Telecommunications and Green Transformation) to 48 % of total sales by fiscal 2028. Going forward, Zeon will continue to contribute to a 'sustainable planet' and 'safe and comfortable society’ by investing in and supporting innovative companies and developing new materials that can transform various fields and industries.

(ID:50715153)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent